ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/EquitiesArticle

Turkey’s BIST 100 slips 0.09% as tech, telecoms weigh

The Istanbul benchmark fell after declines in technology and telecom shares offset gains in select industrials. Gold futures rose to a record near $4,731 an ounce.

PA
Priya Anand · Equities & Earnings Desk · 25 Aug 2026 · 22:52 · 1 min read
Share
Turkey’s BIST 100 slips 0.09% as tech, telecoms weigh

Turkey’s main equity gauge ended lower on Monday, with the BIST 100 falling 0.09% as losses in the information technology, technology and telecoms sectors weighed on sentiment.

Advancing issues outnumbered decliners by 343 to 271 on the Istanbul Stock Exchange, with 28 stocks unchanged. The dollar-lira exchange rate edged up 0.10% to 48.08, while the euro-lira rate rose 0.01% to 56.13.

Among individual movers, Pasifik Teknoloji A.S. led gains with a 9.98% advance to 22.04 lira, followed by Borusan Birlesik Boru Fabrikalari Sanayi Ve Ticaret AS, which added 9.05% to close at 753.00 lira. Pasifik Eurasia Lojistik Dis Ticaret AS reached a record high, climbing 8.75% to 220.00 lira.

On the downside, Odine Solutions Teknoloji Ticaret ve Sanayi AS slumped 9.99% to 1,856.00 lira, while Katilimevim Tasarruf Finansman AS fell 7.72% to 58.60 lira. Balsu Gida Sanayi ve Ticaret AS declined 5.35% to 10.79 lira.

Global markets showed mixed signals, with the U.S. Dollar Index futures up 0.14% at 98.86. In commodities, December gold futures rose 1.09% to $4,731.41 per troy ounce, nearing record territory. October crude oil futures fell 2.92% to $84.52 per barrel, while November Brent crude declined 2.54% to $90.32 per barrel.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT